Jane Qian
Impact in
-
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
-
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 13
- PARP inhibition in cancer therapy 11
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 3
-
- Lung Cancer Treatments and Mutations 4
- Brain Metastases and Treatment 3
- Advanced Breast Cancer Therapies 3
- Renal cell carcinoma treatment 2
- Co-authors
- Kyle D. Holen (3 shared papers)Minesh P. Mehta (3 shared papers)Vincent L. Giranda (9 shared papers)Hao Xiong (4 shared papers)Pierre Chabot (2 shared papers)Cristóbal Belda-Iniesta (2 shared papers)Jeong‐Seon Ryu (2 shared papers)Ebenezer A. Kio (5 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Journal of Neuro-Oncology (2 papers)Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)American Journal of Therapeutics (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Jane Qian
16 papers receiving 277 citations
Peers
Comparison fields: 5 of 40
- Oncology 195
- Pulmonary and Respiratory Medicine 83
- Genetics 25
- Molecular Biology 113
- Cancer Research 18
Countries citing papers authored by Jane Qian
This map shows the geographic impact of Jane Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Qian more than expected).
Fields of papers citing papers by Jane Qian
This network shows the impact of papers produced by Jane Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Qian. The network helps show where Jane Qian may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 85 | |
| 2 | 2016 | 78 | |
| 3 | 2011 | 42 | |
| 4 | 2015 | 26 | |
| 5 | 2015 | 9 | |
| 6 | 2010 | 6 | |
| 7 | 2014 | 6 | |
| 8 | 2012 | 4 | |
| 9 | 2011 | 4 | |
| 10 | 2015 | 4 | |
| 11 | 2009 | 3 | |
| 12 | 2014 | 3 | |
| 13 | 2011 | 3 | |
| 14 | 1998 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2015 | 0 |
About Jane Qian
Jane Qian is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 279 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (11 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Treatment and Pharmacology (3 papers), Brain Metastases and Treatment (3 papers), Advanced Breast Cancer Therapies (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (195 citations), Pulmonary and Respiratory Medicine (83 citations), Genetics (25 citations), Molecular Biology (113 citations) and Cancer Research (18 citations). Jane Qian has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Kyle D. Holen, Minesh P. Mehta, Vincent L. Giranda, Hao Xiong, Pierre Chabot, Cristóbal Belda-Iniesta, Jeong‐Seon Ryu, Ebenezer A. Kio, Qin Qin and В. А. Горбунова. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Cancer Research, Cancer Chemotherapy and Pharmacology and American Journal of Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.